Dr. Navin Kapur Discusses pMCS devices at CHIP Course

February 5, 2016

As part of the “CHIP: Hemodynamic Support and Complex PCI” event, Dr. Navin Kapur from Tufts Medical Center discussed percutaneous devices for mechanical circulatory support, demonstrating a patient case with advanced congestive heart failure and multi-vessel coronary artery disease. Dr. Kapur noted that less than 20% of patients with congestive heart failure are evaluated for ischemic heart disease. Dr. Kapur’s patient was evaluated with thallium testing, which revealed viable myocardiaum appropriate for revascularization. Dr. Kapur discussed this case in terms of the hemodynamic support equation, which consists of circulatory support, ventricular support and coronary perfusion, as detailed below:


Dr. Kapur emphasized that circulatory support, ventricular support, and coronary perfusion are the three elements of mechanical circulatory support (MCS). The goal of MCS is pressure and volume unloading. He compared and contrasted various technologies used for MCS today, including the Tandem Heart device, extracorporeal membrane oxygenation (“ECMO”) and the IABP, in addition to the Impella platform of devices.

Next Steps:

  1. Learn more about the hemodynamics of Protected PCI with the Impella 2.5 heart pump
  2. Learn more about the clinical data associated with Protected PCI

To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/